secwatch / observer
8-K filed February 9, 2026, 6:59 PM ET ticker VNRX CIK 0000093314
regulatory confidence high sentiment negative materiality 0.75

VOLITIONRX LTD (VNRX): Nasdaq/NYSE listing notice — VolitionRx receives NYSE American non-compliance notice for stockholders' equity; must submit plan by March 8, 2026

VOLITIONRX LTD

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

VOLITIONRX LTD received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).

Exchange
nyse american
Notice
noncompliance notice
Deficiency
stockholders equity
Rules
1003(a)(i), 1003(a)(ii), 1003(a)(iii)
Exact text from the filing
February 6, 2026, VolitionRx Limited (the “Company”) received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, Section 1003(a)(ii) of the Company Guide requiring a company to have stockholders’ equit
View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

VOLITIONRX LTD filing history →

Source: SEC EDGAR
accession 0001477932-26-000714
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.